Short Communication: In VitroSynergy between Peptides or Neutralizing Antibodies Targeting the N- and C-Terminal Heptad Repeats of HIV Type 1 gp41

2008 ◽  
Vol 24 (12) ◽  
pp. 1537-1544 ◽  
Author(s):  
Renee Hrin ◽  
Donna L. Montgomery ◽  
Fubao Wang ◽  
Jon H. Condra ◽  
Zhiqiang An ◽  
...  
Keyword(s):  
Neutralizing Antibodies ◽  
Short Communication ◽  
Hiv Type 1 ◽  
Heptad Repeats

HIV Type 1 Subtype E-Infected Patients with Broadened, Dual (B/E) V3 Loop Serology Have Increased Cross-Neutralizing Antibodies

2001 ◽  
Vol 17 (1) ◽  
pp. 69-79 ◽  
Author(s):  
Victoria R. Polonis ◽  
Mark S. de Souza ◽  
Penprapa Chanbancherd ◽  
Somsak Chantakulkij ◽  
Achara Jugsudee ◽  
...  
Keyword(s):  
Neutralizing Antibodies ◽  
V3 Loop ◽  
Hiv Type 1

scholarly journals Membrane-Anchored Peptide Inhibits Human Immunodeficiency Virus Entry

2001 ◽  
Vol 75 (6) ◽  
pp. 3038-3042 ◽  
Author(s):  
Markus Hildinger ◽  
Matthias T. Dittmar ◽  
Patricia Schult-Dietrich ◽  
Boris Fehse ◽  
Barbara S. Schnierle ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
T Helper ◽  
Immunodeficiency Virus ◽  
Retrovirus Vector ◽  
Human Immunodeficiency Virus Entry ◽  
Hiv Type 1 ◽  
Heptad Repeats ◽  
Hiv 1 ◽  
Gp41 Envelope

ABSTRACT Peptides derived from the heptad repeats of human immunodeficiency virus (HIV) gp41 envelope glycoprotein, such as T20, can efficiently inhibit HIV type 1 (HIV-1) entry. In this study, replication of HIV-1 was inhibited more than 100-fold in a T-helper cell line transduced with a retrovirus vector expressing membrane-anchored T20 on the cell surface. Inhibition was independent of coreceptor usage.

Short Communication: Non-B HIV Type 1 Subtypes: Replicative Capacity and Response to Antiretroviral Therapy

2004 ◽  
Vol 20 (8) ◽  
pp. 816-818 ◽  
Author(s):  
Emanuele Nicastri ◽  
Loredana Sarmati ◽  
Gabriella D'Ettorre ◽  
Saverio G. Parisi ◽  
Lucia Palmisano ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Short Communication ◽  
Replicative Capacity ◽  
Hiv Type 1

scholarly journals Short Communication: Characterization of Drug-Resistance Mutations in HIV Type 1 Isolates from Drug-Naive and ARV-Treated Patients in Bulgaria

2008 ◽  
Vol 24 (9) ◽  
pp. 1133-1138 ◽  
Author(s):  
Maria Mercedes Santoro ◽  
Massimo Ciccozzi ◽  
Claudia Alteri ◽  
Stefania Montieri ◽  
Ivailo Alexiev ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Short Communication ◽  
Resistance Mutations ◽  
Drug Resistance Mutations ◽  
Drug Naïve ◽  
Hiv Type 1

Short Communication: Intracellular Glutathione as a Possible Direct Blocker of HIV Type 1 Reverse Transcription

1996 ◽  
Vol 12 (17) ◽  
pp. 1635-1638 ◽  
Author(s):  
MASANORI KAMEOKA ◽  
YOHEI OKADA ◽  
MINORU TOBIUME ◽  
TAKURO KIMURA ◽  
KAZUYOSHI IKUTA
Keyword(s):  
Reverse Transcription ◽  
Short Communication ◽  
Intracellular Glutathione ◽  
Hiv Type 1

Short Communication: Examination of HIV Type 1 Variants in Mother–Child Pairs

1996 ◽  
Vol 12 (10) ◽  
pp. 925-930 ◽  
Author(s):  
WILLIAM W. ROTH ◽  
JALAL A. ZUBERI ◽  
H. GENE STRINGER ◽  
SANDRA K. DAVIDSON ◽  
VINCENT C. BOND
Keyword(s):  
Short Communication ◽  
Hiv Type 1
Sign in / Sign up

Export Citation Format

Share Document